Skip to main content
Caplight Logo









Peptobiotics

Peptobiotics

Private
SingaporeHealthcare & Life Scienceshttps://peptobiotics.com/

Last Round

Series A

Apr 9, 2024

Total Funding Raised

$6.38M

Company Overview

Peptobiotics is a biotechnology company that develops antimicrobial peptide technology to replace the use of antibiotics in agriculture.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

antimicrobial peptidesantibiotic alternativefeed additiveprecision fermentationsynthetic biologysynbioaquacultureagricultural biotechnologyag biotechanimal healthdrug resistanceaquatechrecombinant peptidesshrimp aquaculturelivestock feedgrowth promoterpeptide engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Peptobiotics Comparables

Compare Peptobiotics with similar companies based on industry and business-model similarity.

Peptobiotics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Proteon Pharmaceuticals
79%
NovoBind Livestock Therapeutics Inc.
76%
Phagos
71%

Peptobiotics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 9, 2024
GrantOct 27, 2022
SeedJan 1, 2022

Key People

Founding team and executive leadership

Jhee Hong Koh

Chief Technology Officer Cofounder

Founding Team

Marc Sohier

Chief Operating Officer

Executive Team

Peptobiotics Investors

Notable investors and investment history

Peptobiotics investors
InvestorRounds
Startup SGGrant
SEEDS CapitalSeries A
Ponderosa VenturesSeed
Ponderosa VenturesSeries A
The Trendlines GroupSeed, Series A
The Yield Lab Asia PacificSeed, Series A
Entrepreneurs FirstSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors increased 313% MoM.

  • May 1, 2025

    Monthly visitors grew 146% MoM, from 91 to 224.

Peptobiotics Filings

Explore SEC and related filing metadata, where available.

Peptobiotics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Peptobiotics's valuation, stock price, and market status.

Is Peptobiotics a public or private company?

Peptobiotics is a private company.

What is the current stock price of Peptobiotics?

Peptobiotics is a private company with no public stock price. No recent secondary market data is available.

How much is Peptobiotics worth (valuation)?

Valuation information for Peptobiotics is not publicly available.

Can I buy Peptobiotics stock?

Peptobiotics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Peptobiotics's last funding round?

Peptobiotics's most recent funding round was Series A on April 9, 2024.

Who are the main investors in Peptobiotics?

Key investors in Peptobiotics include Hatch Blue.

Will Peptobiotics IPO soon?

No public IPO plans have been announced for Peptobiotics.

How can I track Peptobiotics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Peptobiotics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range18
Year Founded2020
Last FundingApr 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?